Breast Cancer Trial, Not Yet Recruiting NCT07389200 Sponsor: Hao Xu Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Not Yet Recruiting

NCT07389200
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with breast cancer confirmed through a surgical or biopsy tissue sample.
  • People who have had a specific type of breast imaging scan (called a DCE-MRI) done within two weeks before their surgery.
  • People who have not received any treatment before their initial DCE-MRI scan.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People whose breast lesion (abnormal area) measures less than 5 mm at its longest point.
  • People whose MRI scan images have significant blurring or distortion caused by movement during the scan.
  • People whose medical records have missing or incomplete key information required for the trial.
  • People who received any anti-cancer treatment before their MRI scan.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 8618328522934

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Hao Xu
Registry
ClinicalTrials.gov
Start date
1 January 2028
Est. completion
30 December 2029

Primary endpoints

Patients with pathologically confirmed breast cancer who underwent DCE-MRI were included. Radiomic features were extracted, and seven machine learning algorithms were utilized to construct predictive model.The AUC served as the evaluation metric; F1 score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov